| pubmed-article:9690201 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9690201 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:9690201 | lifeskim:mentions | umls-concept:C0079281 | lld:lifeskim |
| pubmed-article:9690201 | lifeskim:mentions | umls-concept:C0017665 | lld:lifeskim |
| pubmed-article:9690201 | lifeskim:mentions | umls-concept:C0003009 | lld:lifeskim |
| pubmed-article:9690201 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:9690201 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:9690201 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9690201 | pubmed:dateCreated | 1998-10-15 | lld:pubmed |
| pubmed-article:9690201 | pubmed:abstractText | We previously showed that chronic administration of an angiotensin converting enzyme (ACE) inhibitor to rats with passive Heymann nephritis (PHN), a model of membranous nephropathy with proteinuria and increased renal synthesis of endothelin-1 (ET-1), reduces urinary proteins and partially limits the exaggerated ET-1 renal synthesis. Here we compared the effect of an ETA receptor antagonist and an ACE-inhibitor given as single therapies with a combination of the two drugs in uninephrectomized PHN rats. | lld:pubmed |
| pubmed-article:9690201 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9690201 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9690201 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9690201 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9690201 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9690201 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9690201 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9690201 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9690201 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9690201 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9690201 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9690201 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9690201 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:9690201 | pubmed:issn | 0085-2538 | lld:pubmed |
| pubmed-article:9690201 | pubmed:author | pubmed-author:RemuzziGG | lld:pubmed |
| pubmed-article:9690201 | pubmed:author | pubmed-author:BenedettiGG | lld:pubmed |
| pubmed-article:9690201 | pubmed:author | pubmed-author:BenigniAA | lld:pubmed |
| pubmed-article:9690201 | pubmed:author | pubmed-author:ZojaCC | lld:pubmed |
| pubmed-article:9690201 | pubmed:author | pubmed-author:CornaDD | lld:pubmed |
| pubmed-article:9690201 | pubmed:author | pubmed-author:MaffiRR | lld:pubmed |
| pubmed-article:9690201 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9690201 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:9690201 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9690201 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9690201 | pubmed:pagination | 353-9 | lld:pubmed |
| pubmed-article:9690201 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:meshHeading | pubmed-meshheading:9690201-... | lld:pubmed |
| pubmed-article:9690201 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9690201 | pubmed:articleTitle | Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy. | lld:pubmed |
| pubmed-article:9690201 | pubmed:affiliation | Mario Negri Institute for Pharmacological Research, Ospedali Riuniti di Bergamo, Italy. | lld:pubmed |
| pubmed-article:9690201 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9690201 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9690201 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9690201 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9690201 | lld:pubmed |
